Jaguar Health Inc (NASDAQ: JAGX) on Friday, plunged -7.23% from the previous trading day, before settling in for the closing price of $0.25. Within the past 52 weeks, JAGX’s price has moved between $0.22 and $21.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 41.53% over the past five years. The company achieved an average annual earnings per share of 99.26%. With a float of $13.59 million, this company’s outstanding shares have now reached $16.40 million.
Let’s look at the performance matrix of the company that is accounted for 49 employees. In terms of profitability, gross margin is 68.65%, operating margin of -284.92%, and the pretax margin is -365.71%.
Jaguar Health Inc (JAGX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Jaguar Health Inc is 17.12%, while institutional ownership is 1.71%.
Jaguar Health Inc (JAGX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 99.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 79.17% during the next five years compared to 86.10% growth over the previous five years of trading.
Jaguar Health Inc (NASDAQ: JAGX) Trading Performance Indicators
Jaguar Health Inc (JAGX) is currently performing well based on its current performance indicators. A quick ratio of 1.36 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -16.10, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -2.06 in one year’s time.
Technical Analysis of Jaguar Health Inc (JAGX)
Jaguar Health Inc (NASDAQ: JAGX) saw its 5-day average volume 1.69 million, a positive change from its year-to-date volume of 0.53 million. As of the previous 9 days, the stock’s Stochastic %D was 7.99%. Additionally, its Average True Range was 0.07.
During the past 100 days, Jaguar Health Inc’s (JAGX) raw stochastic average was set at 3.09%, which indicates a significant decrease from 8.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 265.20% in the past 14 days, which was higher than the 145.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7334, while its 200-day Moving Average is $1.4763. Nevertheless, the first resistance level for the watch stands at $0.2581 in the near term. At $0.2853, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3163. If the price goes on to break the first support level at $0.1999, it is likely to go to the next support level at $0.1689. The third support level lies at $0.1417 if the price breaches the second support level.
Jaguar Health Inc (NASDAQ: JAGX) Key Stats
Market capitalization of the company is 3.79 million based on 16,402K outstanding shares. Right now, sales total 9,760 K and income totals -41,300 K. The company made 3,110 K in profit during its latest quarter, and -9,850 K in sales during its previous quarter.
